ESMO 2019 | PARP inhibitors for ovarian cancer

Name: PARP inhibitors for ovarian cancer
Uploaded: 2019-09-30T00:00:00Z
Duration: 3 min 45 s
Description: Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, OK, talks about the treatment landscape of ovarian cancer with the emergence of PARP inhibitors. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Kathleen Moore • 30 Sep 2019

ESMO 2019

Gynecological Cancer Ovarian Cancer

PAOLA-1 SOLO-1

Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, OK, talks about the treatment landscape of ovarian cancer with the emergence of PARP inhibitors. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.